Pyrazoles as 11-beta-HSD-1
Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for exa...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | QI, LIDA TILLEY, JEFFERSON WRIGHT PIETRANICO-COLE, SHERRIE LYNN MYERS, MICHAEL PAUL FOTOUHI, NADER GILLESPIE, PAUL GOODNOW JR., ROBERT ALAN HAYNES, NANCY-ELLEN ROSSMAN, PAMELA LOREEN ANDERSON, KEVIN WILLIAM ZHANG, QIANG SCOTT, NATHAN ROBERT THAKKAR, KSHITIJ CHHABILBHAI GUERTIN, KEVIN RICHARD |
| description | Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2007228887BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2007228887BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2007228887BB23</originalsourceid><addsrcrecordid>eNrjZJAKqCxKrMrPSS1WSCxWMDTUTUotSdT1CHbRNeRhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGBuZGRhYWFuZOTkbGRCoDAIIPIuU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrazoles as 11-beta-HSD-1</title><source>esp@cenet</source><creator>QI, LIDA ; TILLEY, JEFFERSON WRIGHT ; PIETRANICO-COLE, SHERRIE LYNN ; MYERS, MICHAEL PAUL ; FOTOUHI, NADER ; GILLESPIE, PAUL ; GOODNOW JR., ROBERT ALAN ; HAYNES, NANCY-ELLEN ; ROSSMAN, PAMELA LOREEN ; ANDERSON, KEVIN WILLIAM ; ZHANG, QIANG ; SCOTT, NATHAN ROBERT ; THAKKAR, KSHITIJ CHHABILBHAI ; GUERTIN, KEVIN RICHARD</creator><creatorcontrib>QI, LIDA ; TILLEY, JEFFERSON WRIGHT ; PIETRANICO-COLE, SHERRIE LYNN ; MYERS, MICHAEL PAUL ; FOTOUHI, NADER ; GILLESPIE, PAUL ; GOODNOW JR., ROBERT ALAN ; HAYNES, NANCY-ELLEN ; ROSSMAN, PAMELA LOREEN ; ANDERSON, KEVIN WILLIAM ; ZHANG, QIANG ; SCOTT, NATHAN ROBERT ; THAKKAR, KSHITIJ CHHABILBHAI ; GUERTIN, KEVIN RICHARD</creatorcontrib><description>Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120202&DB=EPODOC&CC=AU&NR=2007228887B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120202&DB=EPODOC&CC=AU&NR=2007228887B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>QI, LIDA</creatorcontrib><creatorcontrib>TILLEY, JEFFERSON WRIGHT</creatorcontrib><creatorcontrib>PIETRANICO-COLE, SHERRIE LYNN</creatorcontrib><creatorcontrib>MYERS, MICHAEL PAUL</creatorcontrib><creatorcontrib>FOTOUHI, NADER</creatorcontrib><creatorcontrib>GILLESPIE, PAUL</creatorcontrib><creatorcontrib>GOODNOW JR., ROBERT ALAN</creatorcontrib><creatorcontrib>HAYNES, NANCY-ELLEN</creatorcontrib><creatorcontrib>ROSSMAN, PAMELA LOREEN</creatorcontrib><creatorcontrib>ANDERSON, KEVIN WILLIAM</creatorcontrib><creatorcontrib>ZHANG, QIANG</creatorcontrib><creatorcontrib>SCOTT, NATHAN ROBERT</creatorcontrib><creatorcontrib>THAKKAR, KSHITIJ CHHABILBHAI</creatorcontrib><creatorcontrib>GUERTIN, KEVIN RICHARD</creatorcontrib><title>Pyrazoles as 11-beta-HSD-1</title><description>Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAKqCxKrMrPSS1WSCxWMDTUTUotSdT1CHbRNeRhYE1LzClO5YXS3Awqbq4hzh66qQX58anFBYnJqXmpJfGOoUYGBuZGRhYWFuZOTkbGRCoDAIIPIuU</recordid><startdate>20120202</startdate><enddate>20120202</enddate><creator>QI, LIDA</creator><creator>TILLEY, JEFFERSON WRIGHT</creator><creator>PIETRANICO-COLE, SHERRIE LYNN</creator><creator>MYERS, MICHAEL PAUL</creator><creator>FOTOUHI, NADER</creator><creator>GILLESPIE, PAUL</creator><creator>GOODNOW JR., ROBERT ALAN</creator><creator>HAYNES, NANCY-ELLEN</creator><creator>ROSSMAN, PAMELA LOREEN</creator><creator>ANDERSON, KEVIN WILLIAM</creator><creator>ZHANG, QIANG</creator><creator>SCOTT, NATHAN ROBERT</creator><creator>THAKKAR, KSHITIJ CHHABILBHAI</creator><creator>GUERTIN, KEVIN RICHARD</creator><scope>EVB</scope></search><sort><creationdate>20120202</creationdate><title>Pyrazoles as 11-beta-HSD-1</title><author>QI, LIDA ; TILLEY, JEFFERSON WRIGHT ; PIETRANICO-COLE, SHERRIE LYNN ; MYERS, MICHAEL PAUL ; FOTOUHI, NADER ; GILLESPIE, PAUL ; GOODNOW JR., ROBERT ALAN ; HAYNES, NANCY-ELLEN ; ROSSMAN, PAMELA LOREEN ; ANDERSON, KEVIN WILLIAM ; ZHANG, QIANG ; SCOTT, NATHAN ROBERT ; THAKKAR, KSHITIJ CHHABILBHAI ; GUERTIN, KEVIN RICHARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2007228887BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>QI, LIDA</creatorcontrib><creatorcontrib>TILLEY, JEFFERSON WRIGHT</creatorcontrib><creatorcontrib>PIETRANICO-COLE, SHERRIE LYNN</creatorcontrib><creatorcontrib>MYERS, MICHAEL PAUL</creatorcontrib><creatorcontrib>FOTOUHI, NADER</creatorcontrib><creatorcontrib>GILLESPIE, PAUL</creatorcontrib><creatorcontrib>GOODNOW JR., ROBERT ALAN</creatorcontrib><creatorcontrib>HAYNES, NANCY-ELLEN</creatorcontrib><creatorcontrib>ROSSMAN, PAMELA LOREEN</creatorcontrib><creatorcontrib>ANDERSON, KEVIN WILLIAM</creatorcontrib><creatorcontrib>ZHANG, QIANG</creatorcontrib><creatorcontrib>SCOTT, NATHAN ROBERT</creatorcontrib><creatorcontrib>THAKKAR, KSHITIJ CHHABILBHAI</creatorcontrib><creatorcontrib>GUERTIN, KEVIN RICHARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>QI, LIDA</au><au>TILLEY, JEFFERSON WRIGHT</au><au>PIETRANICO-COLE, SHERRIE LYNN</au><au>MYERS, MICHAEL PAUL</au><au>FOTOUHI, NADER</au><au>GILLESPIE, PAUL</au><au>GOODNOW JR., ROBERT ALAN</au><au>HAYNES, NANCY-ELLEN</au><au>ROSSMAN, PAMELA LOREEN</au><au>ANDERSON, KEVIN WILLIAM</au><au>ZHANG, QIANG</au><au>SCOTT, NATHAN ROBERT</au><au>THAKKAR, KSHITIJ CHHABILBHAI</au><au>GUERTIN, KEVIN RICHARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrazoles as 11-beta-HSD-1</title><date>2012-02-02</date><risdate>2012</risdate><abstract>Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2007228887BB2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | Pyrazoles as 11-beta-HSD-1 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T11%3A52%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=QI,%20LIDA&rft.date=2012-02-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2007228887BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |